Sponsor: 
Sanofi-Aventis Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Adults aged ≥65 years only

Registered for use in people aged ≥65 years.

Trivalent inactivated influenza vaccine

Each 0.5 mL monodose pre-filled syringe contains:

  • 60 µg haemagglutinin of each of the 3 recommended influenza virus strains
  • <1 µg ovalbumin
  • ≤100 µg formaldehyde
  • ≤250 µg octoxinol 9

For detailed advice on vaccine dosage, administration, contraindications and precautions, please visit the relevant disease chapter.

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018